双相情感障碍中医证候辨证分型标准专家共识

2021-11-30 中国中西医结合学会精神疾病专业委员会 现代中医临床

双相情感障碍是精神科临床的常见病,中医药治疗该病有优势和特色,辨证论治是中医的核心,而证候是核心中的核心,目前尚缺乏统一的标准。

中文标题:

双相情感障碍中医证候辨证分型标准专家共识

发布日期:

2021-11-30

简要介绍:

双相情感障碍是精神科临床的常见病,中医药治疗该病有优势和特色,辨证论治是中医的核心,而证候是核心中的核心,目前尚缺乏统一的标准,为此中国中西医结合学会精神疾病专业委员会在古今文献研究、临床流行病学调查和德尔菲法研究的基础之上,先后3次组织专家对双相情感障碍的中医证候分型及证-症关系进行讨论,最后确定了双相情感障碍中医辨证分型的专家共识标准。该标准将双相情感障碍的中医证候分为躁狂发作3个证候,抑郁发作5个证候,每个证候需满足主证4项加次证5项方可成立,同时对相关四诊信息进行量化处理,使研究工作能够进行统一和量化,以便在临床研究中进行中医证候疗效评分。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=双相情感障碍中医证候辨证分型标准专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=4bb131c002282e8b, title=双相情感障碍中医证候辨证分型标准专家共识, enTitle=, guiderFrom=现代中医临床, authorId=0, author=, summary=双相情感障碍是精神科临床的常见病,中医药治疗该病有优势和特色,辨证论治是中医的核心,而证候是核心中的核心,目前尚缺乏统一的标准。, cover=https://img.medsci.cn/2021123/1638524899080_5579292.jpg, journalId=0, articlesId=null, associationId=2197, associationName=中国中西医结合学会精神疾病专业委员会, associationIntro=中国中西医结合学会精神疾病专业委员会, copyright=0, guiderPublishedTime=Tue Nov 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">双相情感障碍是精神科临床的常见病,中医药治疗该病有优势和特色,辨证论治是中医的核心,而证候是核心中的核心,目前尚缺乏统一的标准,为此中国中西医结合学会精神疾病专业委员会在古今文献研究、临床流行病学调查和德尔菲法研究的基础之上,先后3次组织专家对双相情感障碍的中医证候分型及证-症关系进行讨论,最后确定了双相情感障碍中医辨证分型的专家共识标准。该标准将双相情感障碍的中医证候分为躁狂发作3个证候,抑郁发作5个证候,每个证候需满足主证4项加次证5项方可成立,同时对相关四诊信息进行量化处理,使研究工作能够进行统一和量化,以便在临床研究中进行中医证候疗效评分。&nbsp;</span></p>, tagList=[TagDto(tagId=8328, tagName=双相情感障碍)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=8328, guiderKeyword=双相情感障碍, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3698, appHits=107, showAppHits=0, pcHits=988, showPcHits=3591, likes=0, shares=7, comments=4, approvalStatus=1, publishedTime=Fri Dec 03 17:55:04 CST 2021, publishedTimeString=2021-11-30, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Dec 03 17:48:51 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 19:46:03 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=双相情感障碍中医证候辨证分型标准专家共识.pdf)])
双相情感障碍中医证候辨证分型标准专家共识.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2115651, encodeId=0f59211565116, content=参考学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef68112305, createdName=ms1000000439125996, createdTime=Tue Feb 21 09:40:50 CST 2023, time=2023-02-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1083348, encodeId=ef5e1083348f8, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:51 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083347, encodeId=73d7108334ed6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:50 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083346, encodeId=9e5d10833462b, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:47 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2023-02-21 ms1000000439125996 来自广东省

    参考学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2115651, encodeId=0f59211565116, content=参考学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef68112305, createdName=ms1000000439125996, createdTime=Tue Feb 21 09:40:50 CST 2023, time=2023-02-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1083348, encodeId=ef5e1083348f8, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:51 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083347, encodeId=73d7108334ed6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:50 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083346, encodeId=9e5d10833462b, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:47 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2021-12-22 一己怀

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2115651, encodeId=0f59211565116, content=参考学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef68112305, createdName=ms1000000439125996, createdTime=Tue Feb 21 09:40:50 CST 2023, time=2023-02-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1083348, encodeId=ef5e1083348f8, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:51 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083347, encodeId=73d7108334ed6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:50 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083346, encodeId=9e5d10833462b, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:47 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2021-12-22 一己怀

    谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2115651, encodeId=0f59211565116, content=参考学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ef68112305, createdName=ms1000000439125996, createdTime=Tue Feb 21 09:40:50 CST 2023, time=2023-02-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1083348, encodeId=ef5e1083348f8, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:51 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083347, encodeId=73d7108334ed6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:50 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083346, encodeId=9e5d10833462b, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Dec 22 23:54:47 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2021-12-22 一己怀

    谢谢分享

    0

拓展阅读

2023 NICE 临床指南:双相情感障碍的评估和管理 [CG185]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2023-12-21